393 related articles for article (PubMed ID: 30011853)
41. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.
Yuan FL; Xu RS; Jiang DL; He XL; Su Q; Jin C; Li X
Bone; 2015 Jun; 75():128-37. PubMed ID: 25708053
[TBL] [Abstract][Full Text] [Related]
42. Effect of the combinatory mixture of Rubus coreanus Miquel and Astragalus membranaceus Bunge extracts on ovariectomy-induced osteoporosis in mice and anti-RANK signaling effect.
Jung Koo H; Sohn EH; Kim YJ; Jang SA; Namkoong S; Chan Kang S
J Ethnopharmacol; 2014 Feb; 151(2):951-9. PubMed ID: 24333364
[TBL] [Abstract][Full Text] [Related]
43. Decursin from Angelica gigas suppresses RANKL-induced osteoclast formation and bone loss.
Wang X; Zheng T; Kang JH; Li H; Cho H; Jeon R; Ryu JH; Yim M
Eur J Pharmacol; 2016 Mar; 774():34-42. PubMed ID: 26825541
[TBL] [Abstract][Full Text] [Related]
44. Antiosteoporotic activity of Davallia formosana.
Ko YJ; Wu JB; Ho HY; Lin WC
J Ethnopharmacol; 2012 Jan; 139(2):558-65. PubMed ID: 22155390
[TBL] [Abstract][Full Text] [Related]
45. Lycorine suppresses RANKL-induced osteoclastogenesis in vitro and prevents ovariectomy-induced osteoporosis and titanium particle-induced osteolysis in vivo.
Chen S; Jin G; Huang KM; Ma JJ; Wang Q; Ma Y; Tang XZ; Zhou ZJ; Hu ZJ; Wang JY; Qin A; Fan SW
Sci Rep; 2015 Aug; 5():12853. PubMed ID: 26238331
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of receptor activator of nuclear factor-κB ligand- or lipopolysaccharide-induced osteoclast formation by conophylline through downregulation of CREB.
Koide N; Kondo Y; Odkhuu E; Ulziisaikhan J; Ukaji T; Yokochi T; Umezawa K
Immunol Lett; 2014 Sep; 161(1):31-7. PubMed ID: 24792671
[TBL] [Abstract][Full Text] [Related]
47. Glycyrrhizic acid suppresses osteoclast differentiation and postmenopausal osteoporosis by modulating the NF-κB, ERK, and JNK signaling pathways.
Yin Z; Zhu W; Wu Q; Zhang Q; Guo S; Liu T; Li S; Chen X; Peng D; Ouyang Z
Eur J Pharmacol; 2019 Sep; 859():172550. PubMed ID: 31323222
[TBL] [Abstract][Full Text] [Related]
48. Orostachys japonicus Suppresses Osteoclast Differentiation by Inhibiting NFATc1 Expression.
Shim KS; Ha H; Kim T; Lee CJ; Ma JY
Am J Chin Med; 2015; 43(5):1013-30. PubMed ID: 26205967
[TBL] [Abstract][Full Text] [Related]
49. KMUP-1 suppresses RANKL-induced osteoclastogenesis and prevents ovariectomy-induced bone loss: roles of MAPKs, Akt, NF-κB and calcium/calcineurin/NFATc1 pathways.
Liou SF; Hsu JH; Lin IL; Ho ML; Hsu PC; Chen LW; Chen IJ; Yeh JL
PLoS One; 2013; 8(7):e69468. PubMed ID: 23936022
[TBL] [Abstract][Full Text] [Related]
50. Yukmijihwang-Tang Suppresses Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-Induced Osteoclast Differentiation and Prevents Ovariectomy (OVX)-Mediated Bone Loss.
Han SY; Kim YK
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946658
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of PRMT5 suppresses osteoclast differentiation and partially protects against ovariectomy-induced bone loss through downregulation of CXCL10 and RSAD2.
Dong Y; Song C; Wang Y; Lei Z; Xu F; Guan H; Chen A; Li F
Cell Signal; 2017 Jun; 34():55-65. PubMed ID: 28302565
[TBL] [Abstract][Full Text] [Related]
52. Protective effects of a polysaccharide BLE0 isolated from barley leaf on bone loss in ovariectomized mice.
Hwang YH; Ha H; Kim R; Cho CW; Song YR; Hong HD; Kim T
Int J Biol Macromol; 2019 Feb; 123():314-321. PubMed ID: 30439432
[TBL] [Abstract][Full Text] [Related]
53. A natural compound (LCA) isolated from Litsea cubeba inhibits RANKL-induced osteoclast differentiation by suppressing Akt and MAPK pathways in mouse bone marrow macrophages.
Yu L; Jia D; Feng K; Sun X; Xu W; Ding L; Xin H; Qin L; Han T
J Ethnopharmacol; 2020 Jul; 257():112873. PubMed ID: 32298753
[TBL] [Abstract][Full Text] [Related]
54. Water extract of Cnidii Rhizoma suppresses RANKL-induced osteoclastogenesis in RAW 264.7 cell by inhibiting NFATc1/c-Fos signaling and prevents ovariectomized bone loss in SD-rat.
Lee KY; Kim JH; Kim EY; Yeom M; Jung HS; Sohn Y
BMC Complement Altern Med; 2019 Aug; 19(1):207. PubMed ID: 31399090
[TBL] [Abstract][Full Text] [Related]
55. Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT.
Hong G; Zhou L; Shi X; He W; Wang H; Wei Q; Chen P; Qi L; Tickner J; Lin L; Xu J
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106828
[TBL] [Abstract][Full Text] [Related]
56. REV-ERB agonism suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss partially via FABP4 upregulation.
Song C; Tan P; Zhang Z; Wu W; Dong Y; Zhao L; Liu H; Guan H; Li F
FASEB J; 2018 Jun; 32(6):3215-3228. PubMed ID: 29401617
[TBL] [Abstract][Full Text] [Related]
57. Esculetin attenuates receptor activator of nuclear factor kappa-B ligand-mediated osteoclast differentiation through c-Fos/nuclear factor of activated T-cells c1 signaling pathway.
Baek JM; Park SH; Cheon YH; Ahn SJ; Lee MS; Oh J; Kim JY
Biochem Biophys Res Commun; 2015 May; 461(2):334-41. PubMed ID: 25887803
[TBL] [Abstract][Full Text] [Related]
58. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
Lee JH; Jin H; Shim HE; Kim HN; Ha H; Lee ZH
Mol Pharmacol; 2010 Jan; 77(1):17-25. PubMed ID: 19828731
[TBL] [Abstract][Full Text] [Related]
59. Nicotinamide phosphoribosyltransferase inhibits receptor activator of nuclear factor-κB ligand-induced osteoclast differentiation in vitro.
Baek JM; Ahn SJ; Cheon YH; Lee MS; Oh J; Kim JY
Mol Med Rep; 2017 Feb; 15(2):784-792. PubMed ID: 28035412
[TBL] [Abstract][Full Text] [Related]
60. Water extract of Acer tegmentosum reduces bone destruction by inhibiting osteoclast differentiation and function.
Ha H; Shim KS; Kim T; An H; Lee CJ; Lee KJ; Ma JY
Molecules; 2014 Apr; 19(4):3940-54. PubMed ID: 24694651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
